Page 29 - ம்ட் ஆண்டர்சன் புற்றுநோய் மையம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana
NeNe Leakes Asks for Prayers as She Reveals Husband Gregg s Cancer Has Returned
aceshowbiz.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from aceshowbiz.com Daily Mail and Mail on Sunday newspapers.
Synaffix B V : Synaffix Licenses its Award-Winning ADC Technology in Deal Adding a New ADC to Innovent s Pipeline
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Acrivon Therapeutics Launches to Advance Clinical Oncology
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.
Rob Halford, Sammy Hagar, Lzzy Hale And Sebastian Bach Among Artists Added To Ronnie James Dio Birthday Virtual Fundraiser
blabbermouth.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from blabbermouth.net Daily Mail and Mail on Sunday newspapers.
Share this article
Share this article
SAN FRANCISCO and SUZHOU, China, June 27, 2021 /PRNewswire/ Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseases today announced that the National Medical Products Administration (NMPA) of China has approved the supplemental New Drug Application (sNDA) for TYVYT® (sintilimab injection) in combination with BYVASDA® (bevacizumab biosimilar injection) as a first-line treatment for people with advanced or unresectable hepatocellular carcinoma (HCC). This is the first regulatory approval of a PD-1 inhibitor-based combination therapy for the first-line treatment for HCC.